Woodline Partners »

Xenon Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.4M 43k 31.30
2024-12-31 $1.6M 40k 39.20
2023-09-30 $4.9M 144k 34.16
2023-06-30 $11M 290k 38.50
2023-03-31 $15M 420k 35.79
2022-12-31 $12M 298k 39.43
2022-09-30 $15M 404k 36.10
2022-06-30 $7.0M 229k 30.42
2021-09-30 $3.1M 200k 15.28